血栓形成症和凝血病的发生
Marzia Savi1, Gregory Hawryluk2
1Department of Intensive Care, Neurosciences and Trauma Critical Care Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.
Neurosurgery clinics of North America
|June 21, 2025
概括
在创伤性脑损伤 (TBI) 和脊髓损伤 (SCI) 中管理抗凝药是关键. 益红素复合缩剂 (PCC) 越来越多地被偏爱用于逆转抗凝,显示出更好的结果和更快的手术.
科学领域:
- 神经科学是一个神经科学.
- 血液学 血液学 血液学
- 临界护理医学 临界护理医学
背景情况:
- 有效的抗凝管理对于创伤性脑损伤 (TBI) 和脊髓损伤 (SCI) 的患者至关重要.
- 在这些患者群体中,平衡血栓栓塞和出血风险是一个重要的临床挑战.
- 目前关于TBI和SCI中抗凝剂逆转策略的证据正在发展.
研究的目的:
- 系统地审查关于TBI和SCI中抗凝管理的文献.
- 评估不同逆转剂的疗效和安全性.
- 确定当前研究和临床实践中的趋势和差距.
主要方法:
- 从1984年1月到2024年8月进行了系统的文献搜索.
- 包括专注于TBI和SCI患者的抗凝固逆转剂的研究.
- 分析了死亡率,静血效率和手术干预时间的数据.
主要成果:
- 观察到越来越多的人倾向于使用前素复合缩物 (PCC) 作为主要逆转剂.
- 在这种背景下,对达比加特兰逆转中idarucizumab的证据有限.
- 研究表明,4F-PCC提高了死亡率和静血疗效,有助于更快地进行手术干预.
结论:
- 血栓复合缩剂 (PCC) 正在成为TBI和SCI中抗凝固逆转的首选药物.
- 需要进行进一步的大规模临床试验,以建立标准化治疗方案.
- 粘弹性测试显示出个性化抗凝剂逆转策略的前景.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
888
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
888
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Pulmonary Embolism I: Introduction
45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45


